Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report
- 1 March 1988
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 145 (3) , 281-285
- https://doi.org/10.1176/ajp.145.3.281
Abstract
There is growing evidence that medication can alleviate symptoms associated with posttraumatic stress disorder (PTSD). Recent research also suggests that PTSD has a unique biological profile consisting of alterations in sympathetic arousal, the neuroendocrine system, and the sleep/dream cycle. This profile distinguishes PTSD from both major depression and panic disorder. Medication appears to alleviate PTSD symptoms associated with sympathetic hyperarousal and intrusive recollections of the trauma but seems ineffective against avoidant symptoms. Pharmacotherapy alone is rarely sufficient to provide complete remission of PTSD. Symptom relief provided by medication facilitates the patient''s participation in individual, behavioral, or group psychotherapy.This publication has 40 references indexed in Scilit:
- Alcoholism in Vietnam and Korea Veterans: a Long Term Follow-upAlcohol, Clinical and Experimental Research, 1984
- Comparison of alprazolam, imipramine, and placebo in the treatment of depressionJAMA, 1983
- Treatment of Traumatic War Neurosis With PhenelzineArchives of General Psychiatry, 1981
- A Specific Laboratory Test for the Diagnosis of MelancholiaArchives of General Psychiatry, 1981
- Long-term effects of traumatic war-related events on sleepAmerican Journal of Psychiatry, 1979
- Psychological Stress, Ego Defenses, and Cortisol Production in Children Hospitalized for Elective SurgeryPsychosomatic Medicine, 1979
- SLEEP PATTERNS IN 3 ACUTE COMBAT FATIGUE CASES1978
- Lactate Metabolism in Anxiety NeurosisNew England Journal of Medicine, 1967
- Adverse Reaction to MarihuanaAmerican Journal of Psychiatry, 1967
- Persistent Stress Reaction After CombatArchives of General Psychiatry, 1965